Acadian Asset Management LLC Puma Biotechnology, Inc. Transaction History
Acadian Asset Management LLC
- $32.5 Billion
- Q2 2024
A detailed history of Acadian Asset Management LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,951,208 shares of PBYI stock, worth $5.52 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,951,208
Previous 1,956,513
0.27%
Holding current value
$5.52 Million
Previous $10.4 Million
38.68%
% of portfolio
0.02%
Previous 0.04%
Shares
23 transactions
Others Institutions Holding PBYI
# of Institutions
98Shares Held
30.2MCall Options Held
73.5KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA3.6MShares$10.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$10.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.16MShares$8.95 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$8.67 Million0.59% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.75MShares$4.96 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $129M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...